• 2008

Company Description

Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.

Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.